Pathogenesis of Helicobacter pylori infection

Helicobacter

Volumn 7, Issue , 2002, Pages 17-23

  Gerhard, Markus ^a   Rad, Roland ^a   Prinz, Christian ^a   Naumann, Michael ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; CYTOTOXIN; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BLOOD GROUP LEWIS SYSTEM; CARCINOGENESIS; CELLULAR IMMUNITY; DISEASE ASSOCIATION; DISEASE COURSE; GENOMICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOMACH CANCER;

ANIMALS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 0036032194     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.7.s1.3.x     Document Type: Article

References (56)

1. Rad R, Gerhard M, Lang R, et al. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J Immunol 2002;168:3033-41.
2. Mizushima T, Sugiyama T, Komatsu Y, Ishizuka J, Kato M, Asaka M. Clinical relevance of the babA2 genotype of Helicobacter pylori. J Clin Microbiol 2001;39:2463-5.
3. Ottemann KM, Lowenthal AC. Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun 2002;70:1984-90.
4. McGovern KJ, Blanchard TG, Gutierrez JA, Czinn SJ, Krakowka S, Youngman P. gamma-Glutamyltransferase is a Helicobacterpylori virulence factor but is not essential for colonization. Infect Immun 2001;69:4168-73.
5. Eaton KA, Gilbert JV, Joyce EA, et al. In vivo complementation of ureB restores the ability of Helicobacter pylori to colonize. Infect Immun 2002;70:771-8.
6. Fischer W, Buhrdorf R, Gerland E, Haas R. Outer membrane targeting of passenger proteins by the vacuolating cytotoxin autotransporter of Helicobacter pylori. Infect Immun 2001;69:6769-75.
7. McClain MS, Cao P, Iwamoto H, et al. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J Bacteriol 2001;183:6499-508.
8. Kuck D, Kolmerer B, Iking-Konert C, Krammer PH, Stremmel W, Rudi J. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect Immun 2001;69(8):5080-7.
9. Galmiche A, Rassow J, Doye A, et al. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J 2000;19:6361-70.
10. Supajatura V, Ushio H, Wada A, et al. Cutting edge. VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 2002;168:2603-7.
11. Tombola F, Morbiato L, Del Giudice G, Rappuoli R, Zoratti M, Papini E. The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J Clin Invest 2001;108:929-37.
12. Salama NR, Otto G, Tompkins L, Falkow S. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect Immun 2001;69:730-6.
13. Debellis L, Papini E, Caroppo R, Montecucco C, Curci S. Helicobacter pylori cytotoxin VacA increases alkaline secretion in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 2001;281:G1440-8.
14. Evans DJJ, Evans DG. Helicobacterpylori CagA analysis of sequence diversity in relation to phosphorylation motifs and implications for the role of CagA as a virulence factor. Helicobacter 2001;6:187-98.
15. Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol 2001;42:631-44.
16. Puls J, Fischer W, Haas R. Activation of Helicobacter pylori CagA by tyrosine phosphorylation is essential for dephosphorylation of host cell proteins in gastric epithelial cells. Mol Microbiol 2002;43:961-9.
17. Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 2002;43:971-80.
18. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 2002;277:6775-8.
19. Higashi H, Tsutsumi R, Muto S, et al. SHP-26 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002;295:683-6.
20. Ferber D. Carcinogenic bacteria. Cracking gut bugs' cell-skewing strategy. Science 2001;294:2269.
21. Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: Essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 2001;42:1337-48.
22. Selbach M, Moese S, Meyer TF, Backert S. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun 2002;70:665-71.
23. Churin Y, Kardalinou E, Meyer TF, Naumann M. Pathogenicity island-dependent activation of Rho GTPases Rac1 and Cdc42 in Helicobacter pylori infection. Mol Microbiol 2001;40:815-23.
24. Naumann M. Host cell signaling in Helicobacter pylori infection. Int J Med Microbiol 2001;291:299-305.
25. Hirata Y, Maeda S, Mitsuno Y, et al. Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells. Infect Immun 2001;69:3965-71.
26. Mitsuno Y, Maeda S, Yoshida H, et al. Helicobacter pylori activates the proto-oncogene c-fos through SRE transactivation. Biochem Biophys Res Commun 2002;291:868-74.
27. Keates S, Sougioultzis S, Keates AC, et al. cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Biol Chem 2001;276:48127-34.
28. Wessler S, Rapp UR, Wiedenmann B, et al. B-Raf/ Rap1 signaling, but not c-Raf-1/Ras, induces the histidine decarboxylase promoter in Helicobacter pylori infection. FASEB J 2002;16:417-9.
29. Jiang HX, Pu H, Huh NH, Yokota K, Oguma K, Namba M. Helicobacter pylori induces pepsinogen secretion by rat gastric cells in culture via a cAMP signal pathway. Int J Mol Med 2001;7:625-9.
30. Yoshimura T, Tomita T, Dixon MF, Axon AT, Robinson PA, Crabtree JE. ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa. J Infect Dis 2002;185:332-40.
31. Cox JM, Clayton CL, Tomita T, Wallace DM, Robinson PA, Crabtree JE. cDNA array analysis of cag pathogenicity island-associated Helicobacter pylori epithelial cell response genes. Infect Immun 2001;69:6970-80.
32. Kawahara T, Kuwano Y, Teshima-Kondo S, et al. Helicobacter pylori lipopolysaccharide from type I, but not type II strains, stimulates apoptosis of cultured gastric mucosal cells. J Med Invest 2001;48:167-74.
33. Le'Negrate G, Ricci V, Hofman V, Mograbi B, Hofman P, Rossi B. Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype. Infect Immun 2001;69:5001-9.
34. Gupta RA, Polk DB, Krishna U, et al. Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. J Biol Chem 2001;276:31059-66.
35. Kurosawa A, Miwa H, Hirose M, Tsune I, Nagahara A, Sato N. Inhibition of cell proliferation and induction of apoptosis by Helicobacter pylori through increased phosphorylated p53, p21 and B ax expression in endothelial cells. J Med Microbiol 2002;51:385-91.
36. Kim JS, Kim JM, Jung HC, Song IS. Caspase-3 activity and expression of Bci Bcl-2 family in human neutrophils by Helicobacter pylori water-soluble proteins. Helicobacter 2001;6:207-15.
37. Maeda S, Yoshida H, Mitsuno Y, et al. Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Gut 2002;50:771-8.
38. Heneghan MA, McCarthy CF, Janulaityte D, Moran AP. Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity. Infect Immun 2001;69:4774-81.
39. Broutet N, Moran A, Hynes S, Sakarovitch C, Megraud F. Lewis antigen expression and other pathogenic factors in the presence of atrophic chronic gastritis in a European population. J Infect Dis 2002;185:503-12.
40. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
41. Moran AP, Knirel YA, Senchenkova SN, Widmalm G, Hynes SO, Jansson PE. Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in Lewis (x) and Lewis (y) expression by H. pylori lipopolysaccharides. J Biol Chem 2002;277:5785-95.
42. Kawahara T, Kuwano Y, Teshima-Kondo S, et al. Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. J Med Invest 2001;48:190-7.
43. Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, Rokutan K. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun 2001;69:4382-9.
44. Maeda S, Akanuma M, Mitsuno Y, et al. Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J Biol Chem 2001;276:44856-64.
45. Keire DA, Anton P, Faull KF, et al. Diethyl phthalate, a chemotactic factor secreted by Helicobacter pylori. J Biol Chem 2001;276:48847-53.
46. Fox JG, Sheppard BJ, Dangler CA, Whary MT, Ihrig M, Wang TC. Germ-line p53-targeted disruption inhibits helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses. Cancer Res 2002;62:696-702.
47. Eaton KA, Mefford M, Thevenot T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 2001;166:7456-61.
48. Montemurro P, Nishioka H, Dundon WG, et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur J Immunol 2002;32:671-6.
49. Suganuma M, Kurusu M, Okabe S, et al. Helicobacter pylori membrane protein 1. A new carcinogenic factor of Helicobacter pylori. Cancer Res 2001;61:6356-9.
50. Gobert AP, Cheng Y, Wang JY, et al. Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol 2002;168:4692-700.
51. Gobert AP, McGee DJ, Akhtar M, et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival. Proc Natl Acad Sci USA 2001;98:13844-9.
52. Betten A, Bylund J, Cristophe T, et al. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. J Clin Invest 2001;108(8):1221-8.
53. Wang J, Brooks EG, Bamford KB, Denning TL, Pappo J, Ernst PB. Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J Immunol 2001;167:926-34.
54. Akanuma M, Maeda S, Ogura K, et al. The evaluation of putative virulence factors of Helicobacter pylori for gastroduodenal disease by use of a short-term Mongolian gerbil infection model. J Infect Dis 2002;185:341-7.
55. Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 2001;48:765-73.
56. Zavros Y, Rieder G, Ferguson A, Samuelson LC, Merchant JL. Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology 2002;122:119-33.